SCHEMBL23348305

SCHEMBL23348305

N#Cc1c(-n2c3ccc(-c4ccccc4)cc3c3ccc(-c4ccccc4)cc32)c(F)c(F)c(F)c1-n1c2ccc(-c3ccccc3)cc2c2ccc(-c3ccccc3)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 2/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
KDM4A O75164 1/20 0.34
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
TSPO P30536 1/20 0.32
ADORA1 P30542 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
ADORA2A P29274 2/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 2/20 0.32
HPGD P15428 2/20 0.32
MAPK1 P28482 1/20 0.32
PGR P06401 1/20 0.32
HIF1A Q16665 1/20 0.32
KCNJ5 P48544 1/20 0.31
KCNJ3 P48549 1/20 0.31
KCNQ1 P51787 1/20 0.31
CACNA1C Q13936 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23348311 0.90 CYP11B1 (0.36) KDM5BCYP11B1CYP11B2KDM4AESR1
SCHEMBL23348303 0.90 KDM5B (0.34) KDM5BCYP11B1CYP11B2KDM4AESR1
SCHEMBL22250449 0.87 GRIA4 (0.36) CYP11B1CYP11B2ADORA1ADORA2AALDH1A1
SCHEMBL16127446 0.85 KDM5B (0.40) KDM5BCYP11B1CYP11B2KDM4AESR1
SCHEMBL29581709 0.85 ADORA1 (0.39) KDM5BCYP11B1CYP11B2KDM4ATSPO
SCHEMBL16176005 0.85 ADORA1 (0.39) KDM5BCYP11B1CYP11B2KDM4ATSPO
SCHEMBL29380865 0.85 ADORA1 (0.39) KDM5BCYP11B1CYP11B2KDM4ATSPO
SCHEMBL17570521 0.85 ADORA1 (0.39) KDM5BCYP11B1CYP11B2KDM4ATSPO
SCHEMBL23348308 0.85 KDM5B (0.34) KDM5BCYP11B1CYP11B2KDM4AESR1
SCHEMBL22251509 0.85 GRIA4 (0.35) KDM5BCYP11B1CYP11B2ADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CCND2, CCND1, CRY1 KDM5B 3881/4885CYP11B1 1671/4885CYP11B2 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.